DE69227089T2 - Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes - Google Patents
Weizen Alpha-Amylase-Inhibitor zur Behandlung von DiabetesInfo
- Publication number
- DE69227089T2 DE69227089T2 DE69227089T DE69227089T DE69227089T2 DE 69227089 T2 DE69227089 T2 DE 69227089T2 DE 69227089 T DE69227089 T DE 69227089T DE 69227089 T DE69227089 T DE 69227089T DE 69227089 T2 DE69227089 T2 DE 69227089T2
- Authority
- DE
- Germany
- Prior art keywords
- alpha amylase
- inhibitor used
- amylase inhibitor
- treat diabetes
- wheat alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3301684A JPH05139985A (ja) | 1991-11-18 | 1991-11-18 | 糖尿病治療薬 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69227089D1 DE69227089D1 (de) | 1998-10-29 |
DE69227089T2 true DE69227089T2 (de) | 1999-04-22 |
Family
ID=17899897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69227089T Expired - Fee Related DE69227089T2 (de) | 1991-11-18 | 1992-01-31 | Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0543076B1 (de) |
JP (1) | JPH05139985A (de) |
CA (1) | CA2059840C (de) |
DE (1) | DE69227089T2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1045208C (zh) * | 1993-09-24 | 1999-09-22 | 华北制药集团新药研究开发中心 | 异戊他定化合物、其制备方法及生产该化合物的微生物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3950319A (en) * | 1970-01-29 | 1976-04-13 | Farbenfabriken Bayer Aktiengesellschaft | Amylase inhibitor from wheat gluten using alcohol |
JPS61171431A (ja) * | 1985-01-23 | 1986-08-02 | Toyobo Co Ltd | アミラ−ゼ阻害物質およびその製造法 |
US4910297A (en) * | 1987-06-29 | 1990-03-20 | Abi Biotechnology Inc. | Alpha-amylase inhibitor |
JP2757405B2 (ja) * | 1988-12-09 | 1998-05-25 | 日清製粉株式会社 | 小麦から得られるα−アミラーゼインヒビターを含有するダイエット剤 |
JP2757404B2 (ja) * | 1988-12-09 | 1998-05-25 | 日清製粉株式会社 | 小麦からα−アミラーゼインヒビター含有物質を取得する方法 |
-
1991
- 1991-11-18 JP JP3301684A patent/JPH05139985A/ja active Pending
-
1992
- 1992-01-22 CA CA002059840A patent/CA2059840C/en not_active Expired - Fee Related
- 1992-01-31 DE DE69227089T patent/DE69227089T2/de not_active Expired - Fee Related
- 1992-01-31 EP EP92101636A patent/EP0543076B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0543076A3 (en) | 1994-07-06 |
DE69227089D1 (de) | 1998-10-29 |
CA2059840A1 (en) | 1993-05-19 |
EP0543076A2 (de) | 1993-05-26 |
EP0543076B1 (de) | 1998-09-23 |
CA2059840C (en) | 1995-08-29 |
JPH05139985A (ja) | 1993-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
DE59611411D1 (de) | Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz | |
DE69227574T2 (de) | Massnahmen zur Verbesserung von Verstärkern | |
DE68904248D1 (de) | Einrichtung zur behandlung von fluessigkeiten. | |
DE69716647T2 (de) | Biologische behandlung von gebrauchten kaustischen laugen | |
DE69212620D1 (de) | Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie | |
DE69312853T2 (de) | Behandlung von Gummiartikeln | |
KR950704251A (ko) | 프롤릴 엔도펩티다아제 억제 활성을 갖는 화합물 및 그 약학적 용도(compound with prolyl endopeptdase inhibitor activity and pharmaceutical use thereof) | |
KR950700323A (ko) | 엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 아미노아세틸머캅토아세틸아미드 유도체(Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE) | |
DE69634951D1 (de) | Topische verwendung von betulinsäure zur behandlung bösartiger melanome | |
DE69226763T2 (de) | Härten von fluoroelastomeren | |
DE69316203T2 (de) | Elektrochemische behandlung von oberflächen | |
DE69032207D1 (de) | Einführung von bakterien in ovo | |
DE69224173D1 (de) | Behandlung von lignocellulosischen Materialien | |
DE68912685D1 (de) | Reinigung von Glucosaminoglucan abbauenden Enzymen. | |
DE69814444D1 (de) | Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation | |
DE69221617D1 (de) | Aufbereitung von flüssigkeit | |
DE59202663D1 (de) | Verwendung eines UV-Strahlers zur Behandlung von Oberflächen. | |
DE68923219T2 (de) | Behandlung von Abfällen. | |
DE68912670T2 (de) | Behandlung von Celluloseblättern. | |
DE3679781D1 (de) | Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung. | |
DE69227089T2 (de) | Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes | |
DE69306831D1 (de) | Behandlung von Flüssigkeiten | |
DK163088D0 (da) | Dopamin-beta-hydroxylase inhibitor | |
ATE216885T1 (de) | Verwendung von penciclovir zur behandlung von postherpetischer neuralgie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |